As a first step, the Commission has issued guidance to reduce occupational health and safety risks in the healthcare sector, including on the risk related to the exposure to cytostatic or cytotoxic drugs, in a dedicated guide to prevention and good practice.
Mar an chéad chéim, d'eisigh an Coimisiún comhairle i ndáil leis na rioscaí sláinte agus sábháilteachta ag an obair a laghdú in earnáil an chúraim sláinte, lena n-áirítear maidir leis an riosca a bhaineann leis an nochtadh do dhrugaí cíteastatacha nó cíteatocsaineacha, i dtreoir thiomnaithe i ndáil leis an gcosc agus leis an dea-chleachtas.